Sledovat
Fabrice Pierre
Fabrice Pierre
E-mailová adresa ověřena na: vrtx.com
Název
Citace
Citace
Rok
CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy
A Siddiqui-Jain, D Drygin, N Streiner, P Chua, F Pierre, SE O'Brien, ...
Cancer research 70 (24), 10288-10298, 2010
5682010
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for …
F Pierre, PC Chua, SE O’Brien, A Siddiqui-Jain, P Bourbon, M Haddach, ...
Journal of medicinal chemistry 54 (2), 635-654, 2011
3512011
Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer
R Battistutta, G Cozza, F Pierre, E Papinutto, G Lolli, S Sarno, SE O’Brien, ...
Biochemistry 50 (39), 8478-8488, 2011
1872011
Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer
F Pierre, PC Chua, SE O’Brien, A Siddiqui-Jain, P Bourbon, M Haddach, ...
Molecular and cellular biochemistry 356 (1), 37-43, 2011
1752011
Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for cancer therapeutics
M Haddach, MK Schwaebe, J Michaux, J Nagasawa, SE O'Brien, ...
ACS medicinal chemistry letters 3 (7), 602-606, 2012
1632012
Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
PC Chua, JP Whitten
US Patent 7,956,064, 2011
1602011
Discovery of CX-6258. A potent, selective, and orally efficacious pan-Pim kinases inhibitor
M Haddach, J Michaux, MK Schwaebe, F Pierre, SE O’Brien, C Borsan, ...
ACS medicinal chemistry letters 3 (2), 135-139, 2012
962012
Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy: miniperspective
D Drygin, M Haddach, F Pierre, DM Ryckman
Journal of medicinal chemistry 55 (19), 8199-8208, 2012
842012
Systems-based design of bi-ligand inhibitors of oxidoreductases: Filling the chemical proteomic toolbox
DS Sem, B Bertolaet, B Baker, E Chang, AD Costache, S Coutts, Q Dong, ...
Chemistry & biology 11 (2), 185-194, 2004
622004
Modulators of cystic fibrosis transmembrane conductance regulator
MT Miller, C Anderson, V Arumugam, BR Bear, HM Binch, JJ Clemens, ...
US Patent 9,782,408, 2017
602017
7-(4H-1, 2, 4-Triazol-3-yl) benzo [c][2, 6] naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity
F Pierre, E Stefan, AS Nédellec, MC Chevrel, CF Regan, A Siddiqui-Jain, ...
Bioorganic & medicinal chemistry letters 21 (22), 6687-6692, 2011
602011
Novel tricyclic protein kinase modulators
M Haddach, F Pierre
US Patent App. 12/883,688, 2011
542011
Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells
F Pierre, CF Regan, MC Chevrel, A Siddiqui-Jain, D Macalino, N Streiner, ...
Bioorganic & medicinal chemistry letters 22 (9), 3327-3331, 2012
462012
Quinobenzoxazine analogs and methods of using thereof
JP Whitten, F Pierre, M Schwaebe
US Patent App. 12/165,476, 2009
41*2009
Protein kinase modulators
PC Chua, M Haddach, JY Nagasawa, F Pierre, JP Whitten
US Patent 8,168,651, 2012
392012
Novel potent pyrimido [4, 5-c] quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties
F Pierre, SE O’Brien, M Haddach, P Bourbon, MK Schwaebe, E Stefan, ...
Bioorganic & medicinal chemistry letters 21 (6), 1687-1691, 2011
382011
Bez názvu
WO Patent 2009108912:A1, 0
36*
P-38 inhibitors
Q Dong, F Pierre, J Wang
US Patent 7,652,044, 2010
352010
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
AR Abela, T Alcacio, C Anderson, PT Angell, M Baek, JJ Clemens, ...
US Patent 10,793,547, 2020
322020
The constitution of micrococcin P1: the Bycroft–Gowland hypothesis confirmed
B Fenet, F Pierre, E Cundliffe, MA Ciufolini
Tetrahedron letters 43 (13), 2367-2370, 2002
262002
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20